Overview

VALID : VAlproate Versus LIthium in Bipolar Disorders

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Primary Objective : - To compare the efficacy of valproate to lithium in Bipolar I patients suffering from a manic or a mixed episode according to DSM IV TR (APA 2000) [Diagnostic and Statistical Manual of Mental Disorders (DSM) fourth edition (IV)Text Revision (TR)] and over a periode of 3 weeks and 12 weeks of treatment Secondary Objective : - To evaluate the clinical and biological safety of valproate compared to lithium.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Valproic Acid